377 related articles for article (PubMed ID: 33629572)
21. Mutations in SURF1 are important genetic causes of Leigh syndrome in Slovak patients.
Danis D; Brennerova K; Skopkova M; Kurdiova T; Ukropec J; Stanik J; Kolnikova M; Gasperikova D
Endocr Regul; 2018 Apr; 52(2):110-118. PubMed ID: 29715184
[TBL] [Abstract][Full Text] [Related]
22. Phenotypic spectrum of eleven patients and five novel MTFMT mutations identified by exome sequencing and candidate gene screening.
Haack TB; Gorza M; Danhauser K; Mayr JA; Haberberger B; Wieland T; Kremer L; Strecker V; Graf E; Memari Y; Ahting U; Kopajtich R; Wortmann SB; Rodenburg RJ; Kotzaeridou U; Hoffmann GF; Sperl W; Wittig I; Wilichowski E; Schottmann G; Schuelke M; Plecko B; Stephani U; Strom TM; Meitinger T; Prokisch H; Freisinger P
Mol Genet Metab; 2014 Mar; 111(3):342-352. PubMed ID: 24461907
[TBL] [Abstract][Full Text] [Related]
23. Combined MITOchondrial-NUCLEAR (MITO-NUCLEAR) Analysis for Mitochondrial Diseases Diagnosis: Validation and Implementation of a One-Step NGS Method.
Barretta F; Uomo F; Caldora F; Mocerino R; Adamo D; Testa F; Simonelli F; Scudiero O; Tinto N; Frisso G; Mazzaccara C
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239447
[TBL] [Abstract][Full Text] [Related]
24. Exome sequencing covers >98% of mutations identified on targeted next generation sequencing panels.
LaDuca H; Farwell KD; Vuong H; Lu HM; Mu W; Shahmirzadi L; Tang S; Chen J; Bhide S; Chao EC
PLoS One; 2017; 12(2):e0170843. PubMed ID: 28152038
[TBL] [Abstract][Full Text] [Related]
25. Looking beyond the exome: a phenotype-first approach to molecular diagnostic resolution in rare and undiagnosed diseases.
Pena LDM; Jiang YH; Schoch K; Spillmann RC; Walley N; Stong N; Rapisardo Horn S; Sullivan JA; McConkie-Rosell A; Kansagra S; Smith EC; El-Dairi M; Bellet J; Keels MA; Jasien J; Kranz PG; Noel R; Nagaraj SK; Lark RK; Wechsler DSG; Del Gaudio D; Leung ML; Hendon LG; Parker CC; Jones KL; ; Goldstein DB; Shashi V
Genet Med; 2018 Apr; 20(4):464-469. PubMed ID: 28914269
[TBL] [Abstract][Full Text] [Related]
26. Targeted exome sequencing for mitochondrial disorders reveals high genetic heterogeneity.
DaRe JT; Vasta V; Penn J; Tran NT; Hahn SH
BMC Med Genet; 2013 Nov; 14():118. PubMed ID: 24215330
[TBL] [Abstract][Full Text] [Related]
27. Diagnostic Challenges of Neuromuscular Disorders after Whole Exome Sequencing.
Chen PS; Chao CC; Tsai LK; Huang HY; Chien YH; Huang PH; Hwu WL; Hsieh ST; Lee NC; Hsueh HW; Yang CC
J Neuromuscul Dis; 2023; 10(4):667-684. PubMed ID: 37066920
[TBL] [Abstract][Full Text] [Related]
28. The combination of whole-exome sequencing and copy number variation sequencing enables the diagnosis of rare neurological disorders.
Jiao Q; Sun H; Zhang H; Wang R; Li S; Sun D; Yang XA; Jin Y
Clin Genet; 2019 Aug; 96(2):140-150. PubMed ID: 30945278
[TBL] [Abstract][Full Text] [Related]
29. Leigh Syndrome: Spectrum of Molecular Defects and Clinical Features in Russia.
Kistol D; Tsygankova P; Krylova T; Bychkov I; Itkis Y; Nikolaeva E; Mikhailova S; Sumina M; Pechatnikova N; Kurbatov S; Bostanova F; Migiaev O; Zakharova E
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675121
[TBL] [Abstract][Full Text] [Related]
30. Effectiveness of whole exome sequencing in unsolved patients with a clinical suspicion of a mitochondrial disorder in Estonia.
Puusepp S; Reinson K; Pajusalu S; Murumets Ü; Õiglane-Shlik E; Rein R; Talvik I; Rodenburg RJ; Õunap K
Mol Genet Metab Rep; 2018 Jun; 15():80-89. PubMed ID: 30009132
[TBL] [Abstract][Full Text] [Related]
31. Alternative splicing expands the clinical spectrum of NDUFS6-related mitochondrial disorders.
Armirola-Ricaurte C; Zonnekein N; Koutsis G; Amor-Barris S; Pelayo-Negro AL; Atkinson D; Efthymiou S; Turchetti V; Dinopoulos A; Garcia A; Karakaya M; Moris G; Polat AI; Yiş U; Espinos C; Van de Vondel L; De Vriendt E; Karadima G; Wirth B; Hanna M; Houlden H; Berciano J; Jordanova A
Genet Med; 2024 Jun; 26(6):101117. PubMed ID: 38459834
[TBL] [Abstract][Full Text] [Related]
32. Revisiting mitochondrial diagnostic criteria in the new era of genomics.
Witters P; Saada A; Honzik T; Tesarova M; Kleinle S; Horvath R; Goldstein A; Morava E
Genet Med; 2018 Apr; 20(4):444-451. PubMed ID: 29261183
[TBL] [Abstract][Full Text] [Related]
33. Defective mitochondrial protease LonP1 can cause classical mitochondrial disease.
Peter B; Waddington CL; Oláhová M; Sommerville EW; Hopton S; Pyle A; Champion M; Ohlson M; Siibak T; Chrzanowska-Lightowlers ZMA; Taylor RW; Falkenberg M; Lightowlers RN
Hum Mol Genet; 2018 May; 27(10):1743-1753. PubMed ID: 29518248
[TBL] [Abstract][Full Text] [Related]
34. Leigh syndrome caused by mitochondrial DNA-maintenance defects revealed by whole exome sequencing.
Souza PVS; Bortholin T; Teixeira CAC; Seneor DD; Marin VDGB; Dias RB; Farias IB; Badia BML; Silva LHL; Pinto WBVR; Oliveira ASB; DiMauro S
Mitochondrion; 2019 Nov; 49():25-34. PubMed ID: 31271879
[TBL] [Abstract][Full Text] [Related]
35. Assessment of a Targeted Gene Panel for Identification of Genes Associated With Movement Disorders.
Montaut S; Tranchant C; Drouot N; Rudolf G; Guissart C; Tarabeux J; Stemmelen T; Velt A; Fourrage C; Nitschké P; Gerard B; Mandel JL; Koenig M; Chelly J; Anheim M;
JAMA Neurol; 2018 Oct; 75(10):1234-1245. PubMed ID: 29913018
[TBL] [Abstract][Full Text] [Related]
36. Targeted next generation sequencing identifies novel pathogenic variants and provides molecular diagnoses in a cohort of pediatric and adult patients with unexplained mitochondrial dysfunction.
Nogueira C; Silva L; Pereira C; Vieira L; Leão Teles E; Rodrigues E; Campos T; Janeiro P; Gaspar A; Dupont J; Bandeira A; Martins E; Magalhães M; Sequeira S; Vieira JP; Santos H; Vilarinho S; Vilarinho L
Mitochondrion; 2019 Jul; 47():309-317. PubMed ID: 30831263
[TBL] [Abstract][Full Text] [Related]
37. The clinical and genetic characteristics in children with mitochondrial disease in China.
Fang F; Liu Z; Fang H; Wu J; Shen D; Sun S; Ding C; Han T; Wu Y; Lv J; Yang L; Li S; Lv J; Shen Y
Sci China Life Sci; 2017 Jul; 60(7):746-757. PubMed ID: 28639102
[TBL] [Abstract][Full Text] [Related]
38. Whole exome sequencing in neurogenetic odysseys: An effective, cost- and time-saving diagnostic approach.
Córdoba M; Rodriguez-Quiroga SA; Vega PA; Salinas V; Perez-Maturo J; Amartino H; Vásquez-Dusefante C; Medina N; González-Morón D; Kauffman MA
PLoS One; 2018; 13(2):e0191228. PubMed ID: 29389947
[TBL] [Abstract][Full Text] [Related]
39. Next-generation sequencing for mitochondrial diseases: a wide diagnostic spectrum.
Vasta V; Merritt JL; Saneto RP; Hahn SH
Pediatr Int; 2012 Oct; 54(5):585-601. PubMed ID: 22494076
[TBL] [Abstract][Full Text] [Related]
40. Clinical Utility of Whole Exome Sequencing and Targeted Panels for the Identification of Inborn Errors of Immunity in a Resource-Constrained Setting.
Engelbrecht C; Urban M; Schoeman M; Paarwater B; van Coller A; Abraham DR; Cornelissen H; Glashoff R; Esser M; Möller M; Kinnear C; Glanzmann B
Front Immunol; 2021; 12():665621. PubMed ID: 34093558
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
